Skip to main content

Table 2 The effect of artemisinin derivatives on the development of experimental cerebral malaria in PbA-infected ICR mice.

From: Artemisone effective against murine cerebral malaria

Compound

Dose

% ECM

Delay to ECM

(relative to control)

DMSO

50 μl

50-90%*

-

DHA

5 mg/kg/d

90%

-

 

10 mg/kg/d

70%

-

 

20 mg/kg/d

60%

2 days

Artesunate

2 × 5 mg/kg/d

65%

9 days**

Artemisone

5 mg/kg/d

100%

2 days

Artemiside

3 mg/kg/d

Total cure, no ECM**,†

-

  1. Mice (n = 10 mice/group) were treated for two to five days post-inoculation. Death from ECM was apparent in control mice starting on day 7 post-inoculation. Mice which did not die of ECM died of severe anemic malaria.
  2. * In 3 experiments.
  3. ** Significant
  4. † No recrudescence